These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

256 related articles for article (PubMed ID: 28623093)

  • 1. The role of SMARCAL1 in replication fork stability and telomere maintenance.
    Lugli N; Sotiriou SK; Halazonetis TD
    DNA Repair (Amst); 2017 Aug; 56():129-134. PubMed ID: 28623093
    [TBL] [Abstract][Full Text] [Related]  

  • 2. SMARCAL1 maintains telomere integrity during DNA replication.
    Poole LA; Zhao R; Glick GG; Lovejoy CA; Eischen CM; Cortez D
    Proc Natl Acad Sci U S A; 2015 Dec; 112(48):14864-9. PubMed ID: 26578802
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [SMARCAL1, roles and mechanisms in genome stability maintenance].
    Wen YL; Lü KN; Xu XK; Zhang X; Ding L; Pan XF
    Yi Chuan; 2019 Dec; 41(12):1084-1098. PubMed ID: 31857280
    [TBL] [Abstract][Full Text] [Related]  

  • 4. SMARCAL1 and replication stress: an explanation for SIOD?
    Bansbach CE; Boerkoel CF; Cortez D
    Nucleus; 2010; 1(3):245-8. PubMed ID: 21327070
    [TBL] [Abstract][Full Text] [Related]  

  • 5. SMARCAL1 catalyzes fork regression and Holliday junction migration to maintain genome stability during DNA replication.
    Bétous R; Mason AC; Rambo RP; Bansbach CE; Badu-Nkansah A; Sirbu BM; Eichman BF; Cortez D
    Genes Dev; 2012 Jan; 26(2):151-62. PubMed ID: 22279047
    [TBL] [Abstract][Full Text] [Related]  

  • 6. SMARCAL1, the annealing helicase and the transcriptional co-regulator.
    Bansal R; Hussain S; Chanana UB; Bisht D; Goel I; Muthuswami R
    IUBMB Life; 2020 Oct; 72(10):2080-2096. PubMed ID: 32754981
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The SIOD disorder protein SMARCAL1 is an RPA-interacting protein involved in replication fork restart.
    Ciccia A; Bredemeyer AL; Sowa ME; Terret ME; Jallepalli PV; Harper JW; Elledge SJ
    Genes Dev; 2009 Oct; 23(20):2415-25. PubMed ID: 19793862
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A novel splice site mutation in SMARCAL1 results in aberrant exon definition in a child with Schimke immunoosseous dysplasia.
    Carroll C; Hunley TE; Guo Y; Cortez D
    Am J Med Genet A; 2015 Oct; 167A(10):2260-4. PubMed ID: 25943327
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The annealing helicase SMARCAL1 maintains genome integrity at stalled replication forks.
    Bansbach CE; Bétous R; Lovejoy CA; Glick GG; Cortez D
    Genes Dev; 2009 Oct; 23(20):2405-14. PubMed ID: 19793861
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of SMARCAL1 as a component of the DNA damage response.
    Postow L; Woo EM; Chait BT; Funabiki H
    J Biol Chem; 2009 Dec; 284(51):35951-61. PubMed ID: 19841479
    [TBL] [Abstract][Full Text] [Related]  

  • 11. ALTering Cancer by Triggering Telomere Replication Stress through the Stabilization of Promoter G-Quadruplex in
    Panda S; Roychowdhury T; Dutta A; Chakraborty S; Das T; Chatterjee S
    ACS Chem Biol; 2024 Jul; 19(7):1433-1439. PubMed ID: 38959478
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Schimke Immunoosseous Dysplasia associated with undifferentiated carcinoma and a novel SMARCAL1 mutation in a child.
    Carroll C; Badu-Nkansah A; Hunley T; Baradaran-Heravi A; Cortez D; Frangoul H
    Pediatr Blood Cancer; 2013 Sep; 60(9):E88-90. PubMed ID: 23630135
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A structure-specific nucleic acid-binding domain conserved among DNA repair proteins.
    Mason AC; Rambo RP; Greer B; Pritchett M; Tainer JA; Cortez D; Eichman BF
    Proc Natl Acad Sci U S A; 2014 May; 111(21):7618-23. PubMed ID: 24821763
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chromatin changes in SMARCAL1 deficiency: A hypothesis for the gene expression alterations of Schimke immuno-osseous dysplasia.
    Morimoto M; Choi K; Boerkoel CF; Cho KS
    Nucleus; 2016 Nov; 7(6):560-571. PubMed ID: 27813696
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Schimke immuno-osseous dysplasia: a cell autonomous disorder?
    Elizondo LI; Huang C; Northrop JL; Deguchi K; Clewing JM; Armstrong DL; Boerkoel CF
    Am J Med Genet A; 2006 Feb; 140(4):340-8. PubMed ID: 16419127
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HARPing on about the DNA damage response during replication.
    Driscoll R; Cimprich KA
    Genes Dev; 2009 Oct; 23(20):2359-65. PubMed ID: 19833762
    [TBL] [Abstract][Full Text] [Related]  

  • 17. SMARCAL1 and telomeres: Replicating the troublesome ends.
    Poole LA; Cortez D
    Nucleus; 2016 May; 7(3):270-4. PubMed ID: 27355316
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inducible SMARCAL1 knockdown in iPSC reveals a link between replication stress and altered expression of master differentiation genes.
    Pugliese GM; Salaris F; Palermo V; Marabitti V; Morina N; Rosa A; Franchitto A; Pichierri P
    Dis Model Mech; 2019 Oct; 12(10):. PubMed ID: 31515241
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The HARP domain dictates the annealing helicase activity of HARP/SMARCAL1.
    Ghosal G; Yuan J; Chen J
    EMBO Rep; 2011 Jun; 12(6):574-80. PubMed ID: 21525954
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CSB and SMARCAL1 compete for RPA32 at stalled forks and differentially control the fate of stalled forks in BRCA2-deficient cells.
    Batenburg NL; Sowa DJ; Walker JR; Andres SN; Zhu XD
    Nucleic Acids Res; 2024 May; 52(9):5067-5087. PubMed ID: 38416570
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.